PolyOne and Zyvex Receive $4.9m Grant to Develop Carbon Nanotube Composites

PolyOne Corporation (NYSE: POL), a premier provider of specialized polymer materials, services and solutions, and Zyvex Performance Materials, company focused on developing nanotechnology to improve the properties of composite materials, today announced they are recipients of a $4.9 million grant from the Ohio Third Frontier Commission that will fund the further development and production of carbon-nanotube composites. The highly-competitive Third Frontier grant program was created to increase Ohio's high-tech research capabilities by promoting collaborative innovation.

Dr. Cecil Chappelow, vice president, innovation, sustainability and chief innovation officer at PolyOne said, "We are honored by this award and confident that our development efforts will yield a significant portfolio of next-generation thermoplastic materials based on carbon nanotubes."

Funding will be used to support ongoing development work initiated several months ago under a joint development agreement between PolyOne and Zyvex Performance Materials to produce carbon nanotube-filled thermoplastics for structural and electrically conductive applications.

Lance Criscuolo, president of Zyvex Performance Materials explained, "This grant underscores both companies' commitment to the technology and our certainty that Zyvex Performance Materials and PolyOne have the expertise needed to drive thermoplastic nanocomposites to the next level of performance. It will also allow us to accelerate our hiring plans and more rapidly introduce our technology commercially."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.